Literature DB >> 9037090

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia.

I Sora1, N Takahashi, M Funada, H Ujike, R S Revay, D M Donovan, L L Miner, G R Uhl.   

Abstract

Morphine produces analgesia at opiate receptors expressed in nociceptive circuits. mu, delta, and kappa opiate receptor subtypes are expressed in circuits that can modulate nociception and receive inputs from endogenous opioid neuropeptide ligands. The roles played by each receptor subtype in nociceptive processing in drug-free and morphine-treated states have not been clear, however. We produced homologous, recombinant mu, opiate receptor, heterozygous and homozygous knockout animals that displayed approximately 54% and 0% of wild-type levels of mu receptor expression, respectively. These mice expressed kappa receptors and delta receptors at near wild-type levels. Untreated knockout mice displayed shorter latencies on tail flick and hot plate tests for spinal and supraspinal nociceptive responses than wild-type mice. These findings support a significant role for endogenous opioid-peptide interactions with mu opiate receptors in normal nociceptive processing. Morphine failed to significantly reduce nociceptive responses in hot plate or tail flick tests of homozygous mu receptor knockout mice, and heterozygote mice displayed right and downward shifts in morphine analgesia dose-effect relationships. These results implicate endogenous opioid-peptide actions at mu opiate receptors in several tests of nociceptive responsiveness and support mu receptor mediation of morphine-induced analgesia in tests of spinal and supraspinal analgesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037090      PMCID: PMC19828          DOI: 10.1073/pnas.94.4.1544

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain.

Authors:  J D Levine; N C Gordon; H L Fields
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

2.  Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin.

Authors:  A L Svingos; A Moriwaki; J B Wang; G R Uhl; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

3.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

4.  Immunohistochemical mapping of enkephalin containing cell bodies, fibers and nerve terminals in the brain stem of the rat.

Authors:  G R Uhl; R R Goodman; M J Kuhar; S R Childers; S H Snyder
Journal:  Brain Res       Date:  1979-04-20       Impact factor: 3.252

5.  A new device for the rapid measurement of impaired motor function in mice.

Authors:  L L Coughenour; J R Mclean; R B Parker
Journal:  Pharmacol Biochem Behav       Date:  1977-03       Impact factor: 3.533

6.  Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord.

Authors:  P Y Cheng; A L Svingos; H Wang; C L Clarke; S Jenab; I W Beczkowska; C E Inturrisi; V M Pickel
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

7.  Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters.

Authors:  L Zhang; Y Yu; S Mackin; F F Weight; G R Uhl; J B Wang
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

8.  mu Opiate receptor immunoreactivity in rat central nervous system.

Authors:  A Moriwaki; J B Wang; A Svingos; E van Bockstaele; P Cheng; V Pickel; G R Uhl
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

9.  Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography.

Authors:  R R Goodman; S H Snyder; M J Kuhar; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Transgenic superoxide dismutase mice differ in opioid-induced analgesia.

Authors:  G I Elmer; J L Evans; B Ladenheim; C J Epstein; J L Cadet
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

View more
  158 in total

1.  Structural basis for μ-opioid receptor binding and activation.

Authors:  Adrian W R Serohijos; Shuangye Yin; Feng Ding; Josee Gauthier; Dustin G Gibson; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

2.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Sex differences in the effects of adolescent social deprivation on alcohol consumption in μ-opioid receptor knockout mice.

Authors:  Yuki Moriya; Yoshiyuki Kasahara; F Scott Hall; Yasufumi Sakakibara; George R Uhl; Hiroaki Tomita; Ichiro Sora
Journal:  Psychopharmacology (Berl)       Date:  2014-11-04       Impact factor: 4.530

Review 4.  G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Marc G Caron
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

5.  Study on the activation of the opioid receptors by a set of morphine derivatives in a well-defined assay system.

Authors:  Yan Zhang; Zhiwei Wang; D Phillip Cox; Olivier Civelli
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

6.  Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands.

Authors:  Michael A Ansonoff; Philip S Portoghese; John E Pintar
Journal:  Psychopharmacology (Berl)       Date:  2010-03-24       Impact factor: 4.530

7.  Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm.

Authors:  J H Kao; S L Chen; H I Ma; P Y Law; P L Tao; H H Loh
Journal:  J Pharmacol Exp Ther       Date:  2010-06-16       Impact factor: 4.030

8.  Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Authors:  L Gendron; J E Pintar; C Chavkin
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

Review 9.  μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.

Authors:  Marino Convertino; Alexander Samoshkin; Josee Gauthier; Michael S Gold; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-12-06       Impact factor: 5.067

10.  Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity.

Authors:  Catherine Rougeot; Michaël Messaoudi; Véronique Hermitte; Anne Gaëlle Rigault; Thierry Blisnick; Christophe Dugave; Didier Desor; François Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.